DOOR syndrome: deficiency of E1 component of the 2-oxoglutarate dehydrogenase complex
Sankar Surendran1, Kimberlee Michals-Matalon, Stephan Krywawych
1Department of Pediatrics, University of Texas Medical Branch, Galveston, Texas 77555, USA.
Insights
This study identifies a key biochemical marker for DOOR syndrome. Reduced 2-oxoglutarate decarboxylase (E1(0)) activity in patients
Area of Science:
- Genetics
- Biochemistry
- Rare Diseases
Background:
- DOOR syndrome is a rare genetic disorder characterized by onycho-osteodystrophy, dystrophic thumbs, sensorineural deafness, and elevated urinary 2-oxoglutarate.
- The autosomal recessive form of DOOR syndrome has been linked to metabolic disturbances, but a specific biochemical marker was lacking.
Purpose of the Study:
- To investigate the role of 2-oxoglutarate decarboxylase (E1(0)) activity in patients with the autosomal recessive form of DOOR syndrome.
- To determine if E1(0) deficiency can serve as a biochemical marker for this condition.
Main Methods:
- Enzyme activity assays were performed on fibroblasts and white blood cells from four patients across three families diagnosed with DOOR syndrome.
- Activity levels of 2-oxoglutarate decarboxylase (E1(0)) were compared between patients and healthy controls.
Main Results:
- Significantly decreased activity of 2-oxoglutarate decarboxylase (E1(0)) was observed in the fibroblasts and white blood cells of all DOOR syndrome patients.
- E1(0) activity in patients was markedly lower compared to control subjects.
Conclusions:
- This study establishes that E1(0) deficiency is a significant biochemical marker for the autosomal recessive form of DOOR syndrome.
- Identifying E1(0) deficiency aids in the diagnosis and understanding of the metabolic basis of DOOR syndrome.
Abstract:
Four patients from three families with the clinical features of DOOR syndrome (onycho-osteodystrophy, dystrophic thumbs, sensorineural deafness, and increased urinary levels of 2-oxoglutarate) are the subjects of this report. Our report deals with the autosomal recessive form of the disease, wherein the activity of 2-oxoglutarate decarboxylase (E1(0)) in fibroblasts and white blood cells of the patients is decreased. The activity of E1(0) in all patients' fibroblasts and white blood cells was significantly lower compared to the controls. This study demonstrates for the first time that E1(0) deficiency is an important biochemical marker for the autosomal recessive form of DOOR syndrome.
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Protein Import into the Peroxisomes
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Export of Misfolded Proteins out of the ER
Electron Transport Chain: Complex III and IV
Inborn Errors of Metabolism


